Differential involvement of 5-HT1B/1D and 5-HT6 receptors in cognitive and non-cognitive symptoms in Alzheimer's disease
M Garcia-Alloza, WD Hirst, CP Chen… - …, 2004 - nature.com
Growing evidence suggests that a compromised serotonergic system plays an important role
in the pathophysiology of Alzheimer's disease (AD). We assessed the expression of 5-HT …
in the pathophysiology of Alzheimer's disease (AD). We assessed the expression of 5-HT …
Reduced serotonin 5-HT1A receptor binding in the temporal cortex correlates with aggressive behavior in Alzheimer disease
MKP Lai, SWY Tsang, PT Francis, MM Esiri, J Keene… - Brain research, 2003 - Elsevier
Previous studies have implicated brain serotonin 5-HT1A receptors in several CNS
functions, including cognition, mood and emotional states. In Alzheimer disease (AD) …
functions, including cognition, mood and emotional states. In Alzheimer disease (AD) …
The potential utility of 5-HT1A receptor antagonists in the treatment of cognitive dysfunction associated with Alzheimer's disease
LE Schechter, LA Dawson… - Current pharmaceutical …, 2002 - ingentaconnect.com
The 5-HT1A receptor has been extensively studied over the last two decades. There is a
plethora of information describing its anatomical, physiological and biochemical roles in the …
plethora of information describing its anatomical, physiological and biochemical roles in the …
Loss of serotonin 5-HT2A receptors in the postmortem temporal cortex correlates with rate of cognitive decline in Alzheimer's disease
MK Lai, SW Tsang, JT Alder, J Keene, T Hope… - …, 2005 - Springer
Rationale Previous studies have demonstrated reductions of serotonin 5-HT 2A receptors in
the neocortex of Alzheimer's disease (AD) patients. However, it is unclear whether such …
the neocortex of Alzheimer's disease (AD) patients. However, it is unclear whether such …
Involvement of an altered 5-HT 6 receptor function in behavioral symptoms of Alzheimer's disease
B Marcos, M Garcia-Alloza, FJ Gil-Bea… - Journal of …, 2008 - content.iospress.com
We studied the hypothesis that disturbances in 5-HT6 receptor function in the temporal
cortex may contribute to clinical symptoms of Alzheimer's disease (AD). 5-HT6 density and 5 …
cortex may contribute to clinical symptoms of Alzheimer's disease (AD). 5-HT6 density and 5 …
Serotonin 5-HT2A and 5-HT6 receptors in the prefrontal cortex of Alzheimer and normal aging patients
Background It has been hypothesized that alterations of the serotonergic system contribute
to neuropsychiatric symptoms in Alzheimer disease (AD). Cellular expressions of the two …
to neuropsychiatric symptoms in Alzheimer disease (AD). Cellular expressions of the two …
Differential involvement of hippocampal serotonin1A receptors and re-uptake sites in non-cognitive behaviors of Alzheimer's disease
MKP Lai, SW Tsang, MM Esiri, PT Francis… - …, 2011 - Springer
Rationale Previous studies have shown extensive serotonergic deficits in the hippocampus
of Alzheimer's disease (AD) patients. However, it is unclear whether such deficits play a role …
of Alzheimer's disease (AD) patients. However, it is unclear whether such deficits play a role …
[HTML][HTML] 5-HT7 receptors in Alzheimer's disease
Even though the involvement of serotonin (5-hydroxytryptamine; 5-HT) and its receptors in
Alzheimer's disease (AD) is widely accepted, data on the expression and the role of 5-HT 7 …
Alzheimer's disease (AD) is widely accepted, data on the expression and the role of 5-HT 7 …
Serotonin 5-HT6 Receptor Antagonists in Alzheimer's Disease: Therapeutic Rationale and Current Development Status
Alzheimer's disease (AD) is the most common cause of dementia in elderly people. Because
of the lack of effective treatments for this illness, research focused on identifying compounds …
of the lack of effective treatments for this illness, research focused on identifying compounds …
[HTML][HTML] 5-HT6 receptor antagonists as novel cognitive enhancing agents for Alzheimer's disease
N Upton, TT Chuang, AJ Hunter, DJ Virley - Neurotherapeutics, 2008 - Elsevier
Alzheimer's disease (AD) is a devastating neurological condition characterized by a
progressive decline in cognitive performance accompanied by behavioral and psychological …
progressive decline in cognitive performance accompanied by behavioral and psychological …